The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

Annals of Oncology

Volumn 22, Issue 5, 2011, Pages 1228-1235

  Andreou, D ^a   Bielack, S S ^b   Carrle, D ^b   Kevric, M ^b   Kotz, R ^c   Winkelmann, W ^d   Jundt, G ^e   Werner, M ^f   Fehlberg, S ^a   Kager, L ^g   Kuhne T ^h   Lang, S ⁱ   Dominkus, M ^c   Exner, G U ^j   Hardes, J ^d   Hillmann, A ^k   Ewerbeck, V ^l   Heise, U ^m   Reichardt, P ⁿ   Tunn, P U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OLGAHOSPITAL   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^g ST ANNA CHILDREN S HOSPITAL   (Austria)

^h UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

ⁱ UNIVERSITY OF VIENNA   (Austria)

^j BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^k Klinikum Ingolstadt   (Switzerland)

^l UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^m Department of Orthopedics   (Switzerland)

ⁿ HELIOS Klinikum Bad Saarow   (Germany)

more..

Author keywords

Biopsy; Limb sparing surgery; Local recurrence; Osteosarcoma; Surgical margin width

Indexed keywords

ADOLESCENT; ADULT; AGED; AMPUTATION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER RECURRENCE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIMB; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PELVIS TUMOR; PERIOSTEUM; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; SCHOOL CHILD; SHOULDER; SOFT TISSUE; TREATMENT RESPONSE; TUMOR BIOPSY;

EID: 79955505062     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq589     Document Type: Article

References (44)

1. Bielack SS, Kempf-Bielack B, Delling G et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20: 776-790.
2. Bacci G, Longhi A, Versari M et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006; 106: 1154-1161.
3. Weeden S, Grimer RJ, Cannon SR et al. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 2001; 37: 39-46.
4. Rodriguez-Galindo C, Shah N, McCarville MB et al. Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000). Cancer 2004; 100: 1928-1935.
5. Ozaki T, Flege S, Kevric M et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 2003; 21: 334-341.
6. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop Relat Res 1998; 348: 196-207.
7. Picci P, Sangiorgi L, Rougraff BT et al. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 1994; 12: 2699-2705.
8. Bielack SS, Kempf-Bielack B, Winkler K. Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence. J Clin Oncol 1996; 14: 683-684.
9. Bacci G, Forni C, Longhi A et al. Local recurrence and local control of nonmetastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol 2007; 96: 118-123.
10. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106-120.
11. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 1986; 204: 9-24.
12. Grimer RJ, Sommerville S, Warnock D et al. Management and outcome after local recurrence of osteosarcoma. Eur J Cancer 2005; 41: 578-583.
13. Picci P, Sangiorgi L, Bahamonde L et al. Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities. Ann Oncol 1997; 8: 899-903.
14. Grimer RJ, Taminiau AM, Cannon SR. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br 2002; 84: 395-400.
15. Heck RK, Carnesale PG. General principles of tumors. In Canale ST (ed): Campbell's Operative Orthopaedics, 10th edition. Philadelphia, PA: Mosby 2003; 733-792.
16. Gitelis S, Malawer M, MacDonald D, Derman G. Principles of limb salvage surgery. In Chapman MW (ed): Chapman's Orthopaedic Surgery, 3rd edition. Philadelphia, PA: Lippincott Williams and Wilkins 2001; 3309-3381.
17. Bacci G, Ferrari S, Mercuri M et al. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 1998; 69: 230-236.
18. Brosjö O. Surgical procedure and local recurrence in 223 patients treated 1982-1997 according to two osteosarcoma chemotherapy protocols. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 1999; 285: 58-61.
19. Kager L, Zoubek A, Pö tschger U et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003; 21: 2011-2018.
20. Winkler K, Bielack S, Delling G et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer 1990; 66: 1703-1710.
21. Bielack S, Kempf-Bielack B, Schwenzer D et al. Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients. Klin Padiatr 1999; 211: 260-270.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
24. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187-220.
25. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual 6th edition. New York, NY: Springer-Verlag 2002.
26. Aksnes LH, Bauer HC, Jebsen NL et al. Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br 2008; 90: 786-794.
27. Eiser C, Darlington AS, Stride CB, Grimer R. Quality of life implications as a consequence of surgery: limb salvage, primary and secondary amputation. Sarcoma 2001; 5: 189-195.
28. Sluga M, Windhager R, Lang S et al. Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop Relat Res 1999; 358: 120-127.
29. Bacci G, Ferrari S, Lari S et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br 2002; 84: 88-92.
30. Bloem JL, Taminiau AH, Eulderink F et al. Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography, and CT correlated with pathologic examination. Radiology 1988; 169: 805-810.
31. Gillespy T III, Manfrini M, Ruggieri P et al. Staging of intraosseous extent of osteosarcoma: correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology 1988; 167: 765-767.
32. Kumta SM, Chow TC, Griffith J et al. Classifying the location of osteosarcoma with reference to the epiphyseal plate helps determine the optimal skeletal resection in limb salvage procedures. Arch Orthop Trauma Surg 1999; 119: 327-331.
33. Cho HS, Oh JH, Han I, Kim HS. Joint-preserving limb salvage surgery under navigation guidance. J Surg Oncol 2009; 100: 227-232.
34. Baumgart R, Lenze U. Expandable endoprostheses in malignant bone tumors in children: indications and limitations. Recent Results Cancer Res 2009; 179: 59-73.
35. Unwin PS, Cannon SR, Grimer RJ et al. Aseptic loosening in cemented custommade prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg Br 1996; 78: 5-13.
36. Windhager R, Leithner A, Hochegger M. Revision of tumour endoprostheses around the knee joint. Review and own results. Orthopade 2006; 35: 176-183.
37. Picci P, Mercuri M, Ferrari S et al. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol 2010; 21: 1366-1373.
38. Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer 2005; 103: 1891-1897.
39. Mitchell AE, Scarcella DL, Rigutto GL et al. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 2004; 180: 59-62.
40. Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 1982; 64: 1121-1127.
41. Carter SR, Grimer RJ, Sneath RS. A review of 13-years experience of osteosarcoma. Clin Orthop Relat Res 1991; 270: 45-51.
42. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996; 78: 656-663.
43. Werner M, Delling G. Chemotherapy-induced changes in high grade central osteosarcomas-experiences gained through the assignment as referencepathologists of the COSS-studies. Pathologe 2004; 25: 445-453.
44. Spanier SS, Shuster JJ, Vander Griend RA. The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am 1990; 72: 643-653.